Rigel Pharmaceuticals: 15min Chart Triggers MACD Death Cross, KDJ Death Cross

Rigel Pharmaceuticals' 15-minute chart has triggered a MACD Death Cross and KDJ Death Cross at 08/14/2025 12:00, indicating a potential decline in the stock price. The momentum of the stock price is shifting towards the downside, suggesting further decreases in value are possible.

Rigel Pharmaceuticals (NASDAQ:RIGL) has recently experienced a notable shift in its stock price momentum, as indicated by the appearance of a MACD Death Cross and a KDJ Death Cross on its 15-minute chart at 08/14/2025 12:00. These technical indicators suggest a potential decline in the stock price, with the momentum shifting towards the downside.

The MACD Death Cross occurs when the MACD line crosses below the signal line, signaling a bearish trend. Similarly, the KDJ Death Cross, part of the KDJ (Kaufman Adaptive Moving Average) indicator, indicates a potential reversal in the stock's trend. Both of these signals suggest that the stock may continue to decrease in value.

This development comes after Rigel Pharmaceuticals reported strong Q2 earnings, with a significant increase in revenue and net income. However, the technical indicators suggest that the market sentiment towards the stock has shifted, potentially driven by factors such as increased risk perception or a reassessment of the company's growth prospects.

Investors should remain vigilant and monitor the stock's performance closely, as well as the company's future earnings reports and pipeline developments. While the technical indicators provide a potential warning sign, they should not be the sole basis for investment decisions. It is essential to consider the company's fundamentals, market conditions, and other relevant factors.

References:
[1] https://seekingalpha.com/article/4813426-rigel-pharmaceuticals-q2-earnings-fuel-potential-breakout